Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

Purohit’s continued optimism is primarily driven by the strong commercial performance of Auvelity, the company’s treatment ...

Morgan Stanley (MS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Property investor Charter Hall Group was one of the best performing ASX 200 stocks in morning trade, after Morgan Stanley ...

All three major averages closed out May with sizable gains Friday, with the S&P 500 and Nasdaq Composite seeing their best ...

Emerging-market assets should keep rallying for the rest of the year, but gains will likely be limited by a slowing global ...

Morgan Stanley has raised its price target for Performance Food Group Company (NYSE:PFGC) to $93, up from $92, while ...

Compared to the aggregate P/E ratio of the 21.42 in the Capital Markets industry, Morgan Stanley Inc. has a lower P/E ratio ...

Analysts are confident about the athleisure company's upcoming results, but less sure about its long-term prospects.

GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers ...

Brokerages offered a largely tepid take on Ashok Leyland Ltd. post the company's declaration of its financial performance in ...

While Brambles unexpectedly tops the list, there’s fewer surprises in the list of the 10 most-owned ASX stocks: The most ...